On November 16, Illumina fell 4.12% in Regular Trading, trading at $199.13 per share, with turnover of $36.3342 million.
The latest identifiable catalyst is continued market digestion of management commentary delivered on November 10, when executives said the company is on track for high-single-digit revenue growth next year and at least a 25.5% operating margin as a starting point, while stopping short of issuing formal guidance.
That reaction followed the company’s late-October quarterly update, in which adjusted EPS excluding tariff refunds came in at $1.44 versus a $1.36 consensus estimate, while revenue of $1.129 billion missed the $1.154 billion expectation. Illumina also raised full-year adjusted EPS guidance to $5.40-$5.45 from $5.30-$5.40, but weaker China revenue trends remained a point of investor focus. Recent analyst target-price increases provide broader support for sentiment, yet the current move suggests the stock is still consolidating after the earlier rally tied to the medium-term margin and growth discussion.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments